Share Price and Basic Stock Data
Last Updated: January 23, 2026, 9:32 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Thirumalai Chemicals Ltd operates within the specialty chemicals sector, focusing on various chemical products. The company’s reported sales figures have shown fluctuations, with a peak of ₹572 Cr in September 2022, followed by a decline to ₹431 Cr in March 2023. However, a rebound was noted with sales rising to ₹542 Cr in September 2023. The trailing twelve months (TTM) revenue stood at ₹1,865 Cr, reflecting a decrease from ₹2,132 Cr in March 2023. The annual sales figures have shown a consistent pattern of growth from ₹1,275 Cr in March 2014 to ₹2,050 Cr in March 2025, albeit with some volatility in recent quarters. This indicates that while the company has experienced growth over the long term, recent performance reveals challenges that may affect future revenue stability.
Profitability and Efficiency Metrics
Thirumalai Chemicals Ltd has faced significant profitability challenges, as evidenced by its operating profit margin (OPM) which stood at -1% for the latest reporting period. The company recorded a net profit of -₹149 Cr for the TTM, down from ₹90 Cr in March 2023, indicating a notable decline in profitability. Operating profit peaked at ₹441 Cr in March 2022 but fell sharply to ₹49 Cr in March 2025. The interest coverage ratio (ICR) is relatively low at 1.41x, suggesting difficulties in meeting interest obligations. Efficiency metrics reveal a cash conversion cycle (CCC) of -11 days, indicating effective management of working capital. However, the return on equity (ROE) is only 4.13%, a signal of underperformance compared to industry norms, which typically hover around 10-15% for healthy firms in the sector.
Balance Sheet Strength and Financial Ratios
The balance sheet of Thirumalai Chemicals Ltd reflects a concerning leverage position, with borrowings reported at ₹2,086 Cr against reserves of ₹1,521 Cr. The total debt-to-equity ratio stands at 1.48x, indicating a reliance on debt financing. This high leverage could pose risks in periods of low profitability. The company’s book value per share increased to ₹112.86 in March 2025, showcasing some resilience in asset valuation. Additionally, the current ratio of 1.04x suggests that the company can cover its short-term liabilities, albeit marginally. The inventory turnover ratio improved to 8.23x, indicating efficient management of inventory, while the enterprise value (EV) of ₹3,836.01 Cr reflects a higher valuation relative to its operating revenue. This could suggest market optimism, but the underlying financial health remains precarious.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Thirumalai Chemicals Ltd indicates a diversified ownership structure, with promoters holding 36.13% as of September 2025. This is a decline from 42.01% in December 2022, which may raise concerns about insider confidence in the company’s future. Foreign institutional investors (FIIs) own 2.15%, while domestic institutional investors (DIIs) have increased their stake to 9.32%, indicating a growing interest from institutional players despite the company’s recent challenges. The public holds 52.39% of shares, suggesting widespread retail participation. The total number of shareholders has decreased from 81,997 in December 2022 to 58,416 in September 2025, reflecting a potential loss of investor confidence amidst declining performance. The changing dynamics in shareholding may impact future capital raising efforts and market perceptions.
Outlook, Risks, and Final Insight
The outlook for Thirumalai Chemicals Ltd appears mixed, with significant operational challenges and a need for strategic realignment. The company’s reliance on debt financing poses risks, particularly in a rising interest rate environment, which could further strain profitability. Additionally, the declining net profit and OPM indicate that the company must enhance operational efficiency to regain market confidence. However, strengths such as effective inventory management and a solid long-term revenue trajectory provide some grounds for optimism. The company’s ability to navigate these challenges will depend on its strategic initiatives, operational improvements, and market conditions. If Thirumalai can stabilize its financial metrics and restore profitability, it could potentially attract renewed investor interest, but any further deterioration may lead to heightened scrutiny and risk aversion from the market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 345 Cr. | 37.5 | 71.7/36.8 | 21.4 | 20.5 | 1.07 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 28.0 Cr. | 57.0 | 88.8/55.0 | 13.4 | 89.6 | 1.75 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 44.5 Cr. | 655 | 899/600 | 20.5 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,221 Cr. | 71.0 | 111/68.2 | 21.3 | 22.0 | 0.70 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 547 Cr. | 219 | 377/213 | 19.6 | 93.8 | 1.14 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,127.48 Cr | 644.51 | 58.17 | 182.97 | 0.47% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 572 | 508 | 431 | 523 | 542 | 492 | 527 | 555 | 525 | 447 | 523 | 450 | 445 |
| Expenses | 511 | 479 | 432 | 485 | 527 | 498 | 523 | 524 | 502 | 467 | 508 | 477 | 449 |
| Operating Profit | 61 | 29 | -1 | 38 | 15 | -6 | 4 | 31 | 24 | -20 | 15 | -27 | -4 |
| OPM % | 11% | 6% | -0% | 7% | 3% | -1% | 1% | 6% | 4% | -5% | 3% | -6% | -1% |
| Other Income | 6 | 11 | 11 | 5 | 6 | 4 | 4 | 3 | 9 | 0 | 8 | 2 | 8 |
| Interest | 7 | 11 | 7 | 10 | 10 | 12 | 10 | 9 | 10 | 14 | 15 | 18 | 26 |
| Depreciation | 13 | 14 | 16 | 16 | 16 | 15 | 17 | 14 | 13 | 16 | 18 | 22 | 23 |
| Profit before tax | 47 | 14 | -13 | 17 | -4 | -29 | -19 | 11 | 9 | -50 | -11 | -64 | -44 |
| Tax % | 27% | 41% | 0% | 37% | 47% | -20% | 10% | 53% | 47% | -16% | 28% | -7% | -24% |
| Net Profit | 34 | 8 | -13 | 11 | -6 | -23 | -20 | 5 | 5 | -42 | -14 | -60 | -33 |
| EPS in Rs | 3.35 | 0.81 | -1.25 | 1.04 | -0.59 | -2.24 | -2.00 | 0.50 | 0.48 | -4.10 | -1.37 | -5.86 | -2.81 |
Last Updated: December 28, 2025, 8:04 pm
Below is a detailed analysis of the quarterly data for Thirumalai Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 445.00 Cr.. The value appears to be declining and may need further review. It has decreased from 450.00 Cr. (Jun 2025) to 445.00 Cr., marking a decrease of 5.00 Cr..
- For Expenses, as of Sep 2025, the value is 449.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 477.00 Cr. (Jun 2025) to 449.00 Cr., marking a decrease of 28.00 Cr..
- For Operating Profit, as of Sep 2025, the value is -4.00 Cr.. The value appears strong and on an upward trend. It has increased from -27.00 Cr. (Jun 2025) to -4.00 Cr., marking an increase of 23.00 Cr..
- For OPM %, as of Sep 2025, the value is -1.00%. The value appears strong and on an upward trend. It has increased from -6.00% (Jun 2025) to -1.00%, marking an increase of 5.00%.
- For Other Income, as of Sep 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Jun 2025) to 8.00 Cr., marking an increase of 6.00 Cr..
- For Interest, as of Sep 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.00 Cr. (Jun 2025) to 26.00 Cr., marking an increase of 8.00 Cr..
- For Depreciation, as of Sep 2025, the value is 23.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22.00 Cr. (Jun 2025) to 23.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -44.00 Cr.. The value appears strong and on an upward trend. It has increased from -64.00 Cr. (Jun 2025) to -44.00 Cr., marking an increase of 20.00 Cr..
- For Tax %, as of Sep 2025, the value is -24.00%. The value appears to be improving (decreasing) as expected. It has decreased from -7.00% (Jun 2025) to -24.00%, marking a decrease of 17.00%.
- For Net Profit, as of Sep 2025, the value is -33.00 Cr.. The value appears strong and on an upward trend. It has increased from -60.00 Cr. (Jun 2025) to -33.00 Cr., marking an increase of 27.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -2.81. The value appears strong and on an upward trend. It has increased from -5.86 (Jun 2025) to -2.81, marking an increase of 3.05.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:30 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,275 | 1,070 | 940 | 1,028 | 1,312 | 1,261 | 1,085 | 1,086 | 1,998 | 2,132 | 2,083 | 2,050 | 1,865 |
| Expenses | 1,192 | 1,032 | 842 | 871 | 1,022 | 1,055 | 1,007 | 865 | 1,557 | 1,946 | 2,032 | 2,001 | 1,901 |
| Operating Profit | 83 | 38 | 98 | 158 | 290 | 206 | 78 | 221 | 441 | 186 | 51 | 49 | -36 |
| OPM % | 7% | 4% | 10% | 15% | 22% | 16% | 7% | 20% | 22% | 9% | 2% | 2% | -2% |
| Other Income | 3 | 8 | 5 | 4 | 7 | 12 | 21 | 7 | 12 | 30 | 19 | 21 | 19 |
| Interest | 49 | 35 | 23 | 17 | 13 | 12 | 17 | 21 | 20 | 31 | 42 | 49 | 74 |
| Depreciation | 23 | 18 | 25 | 36 | 31 | 36 | 44 | 50 | 57 | 56 | 63 | 61 | 78 |
| Profit before tax | 15 | -7 | 55 | 109 | 253 | 169 | 38 | 157 | 375 | 129 | -35 | -41 | -169 |
| Tax % | 20% | 102% | 41% | 35% | 33% | 33% | 39% | 25% | 25% | 31% | 12% | 13% | |
| Net Profit | 12 | -14 | 32 | 71 | 170 | 114 | 23 | 118 | 281 | 90 | -39 | -46 | -149 |
| EPS in Rs | 1.16 | -1.34 | 3.14 | 6.90 | 16.64 | 11.09 | 2.26 | 11.49 | 27.47 | 8.77 | -3.79 | -4.50 | -14.14 |
| Dividend Payout % | 0% | -30% | 51% | 27% | 12% | 18% | 0% | 19% | 9% | 17% | -26% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -216.67% | 328.57% | 121.88% | 139.44% | -32.94% | -79.82% | 413.04% | 138.14% | -67.97% | -143.33% | -17.95% |
| Change in YoY Net Profit Growth (%) | 0.00% | 545.24% | -206.70% | 17.56% | -172.38% | -46.88% | 492.87% | -274.91% | -206.11% | -75.36% | 125.38% |
Thirumalai Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 14% |
| 3 Years: | 1% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -151% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 36% |
| 3 Years: | 9% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 8% |
| 3 Years: | 0% |
| Last Year: | -4% |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: December 10, 2025, 3:33 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 12 |
| Reserves | 205 | 183 | 208 | 388 | 563 | 658 | 628 | 793 | 1,075 | 1,182 | 1,136 | 1,145 | 1,521 |
| Borrowings | 222 | 142 | 91 | 62 | 50 | 103 | 197 | 183 | 165 | 514 | 1,252 | 1,786 | 2,086 |
| Other Liabilities | 321 | 212 | 211 | 327 | 202 | 370 | 365 | 358 | 612 | 654 | 922 | 867 | 727 |
| Total Liabilities | 757 | 547 | 520 | 786 | 825 | 1,141 | 1,200 | 1,343 | 1,862 | 2,360 | 3,320 | 3,808 | 4,345 |
| Fixed Assets | 230 | 243 | 256 | 317 | 310 | 383 | 550 | 513 | 596 | 671 | 712 | 1,251 | 1,281 |
| CWIP | 18 | 7 | 18 | 9 | 44 | 159 | 82 | 126 | 64 | 406 | 1,200 | 1,352 | 1,740 |
| Investments | 5 | 5 | 5 | 77 | 104 | 150 | 49 | 136 | 180 | 132 | 173 | 200 | 210 |
| Other Assets | 503 | 291 | 241 | 383 | 367 | 449 | 519 | 569 | 1,022 | 1,150 | 1,236 | 1,005 | 1,114 |
| Total Assets | 757 | 547 | 520 | 786 | 825 | 1,141 | 1,200 | 1,343 | 1,862 | 2,360 | 3,320 | 3,808 | 4,345 |
Below is a detailed analysis of the balance sheet data for Thirumalai Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 2.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,521.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,145.00 Cr. (Mar 2025) to 1,521.00 Cr., marking an increase of 376.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2,086.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,786.00 Cr. (Mar 2025) to 2,086.00 Cr., marking an increase of 300.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 727.00 Cr.. The value appears to be improving (decreasing). It has decreased from 867.00 Cr. (Mar 2025) to 727.00 Cr., marking a decrease of 140.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,345.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,808.00 Cr. (Mar 2025) to 4,345.00 Cr., marking an increase of 537.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,281.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,251.00 Cr. (Mar 2025) to 1,281.00 Cr., marking an increase of 30.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,740.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,352.00 Cr. (Mar 2025) to 1,740.00 Cr., marking an increase of 388.00 Cr..
- For Investments, as of Sep 2025, the value is 210.00 Cr.. The value appears strong and on an upward trend. It has increased from 200.00 Cr. (Mar 2025) to 210.00 Cr., marking an increase of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,114.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,005.00 Cr. (Mar 2025) to 1,114.00 Cr., marking an increase of 109.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,345.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,808.00 Cr. (Mar 2025) to 4,345.00 Cr., marking an increase of 537.00 Cr..
However, the Borrowings (2,086.00 Cr.) are higher than the Reserves (1,521.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -139.00 | -104.00 | 7.00 | 96.00 | 240.00 | 103.00 | -119.00 | 38.00 | 276.00 | -328.00 | 50.00 | 48.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 52 | 50 | 49 | 33 | 33 | 30 | 29 | 29 | 17 | 32 | 35 |
| Inventory Days | 74 | 42 | 38 | 82 | 59 | 84 | 69 | 74 | 74 | 76 | 55 | 57 |
| Days Payable | 59 | 38 | 92 | 139 | 53 | 119 | 123 | 129 | 141 | 118 | 113 | 103 |
| Cash Conversion Cycle | 82 | 56 | -3 | -8 | 39 | -2 | -24 | -26 | -39 | -25 | -26 | -11 |
| Working Capital Days | 3 | -8 | -15 | -5 | 37 | 4 | -5 | -19 | -23 | -61 | -93 | -57 |
| ROCE % | 14% | 7% | 24% | 33% | 49% | 26% | 7% | 20% | 35% | 11% | 0% | 0% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Bandhan Small Cap Fund | 600,274 | 0.08 | 14.11 | 577,617 | 2025-12-15 06:52:35 | 3.92% |
| ICICI Prudential Commodities Fund | 499,582 | 0.37 | 11.75 | N/A | N/A | N/A |
| Bandhan Balanced Advantage Fund | 361,010 | 0.37 | 8.49 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| Diluted EPS (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| Cash EPS (Rs.) | 1.46 | 2.38 | 14.21 | 32.99 | 16.33 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 112.86 | 111.93 | 116.40 | 105.96 | 78.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 112.86 | 111.93 | 116.40 | 105.96 | 78.41 |
| Revenue From Operations / Share (Rs.) | 200.15 | 203.43 | 208.23 | 195.14 | 106.03 |
| PBDIT / Share (Rs.) | 6.78 | 6.87 | 21.13 | 44.18 | 22.22 |
| PBIT / Share (Rs.) | 0.81 | 0.69 | 15.69 | 38.65 | 17.39 |
| PBT / Share (Rs.) | -3.99 | -3.37 | 12.64 | 36.66 | 15.34 |
| Net Profit / Share (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| NP After MI And SOA / Share (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| PBDIT Margin (%) | 3.38 | 3.37 | 10.14 | 22.63 | 20.95 |
| PBIT Margin (%) | 0.40 | 0.34 | 7.53 | 19.80 | 16.39 |
| PBT Margin (%) | -1.99 | -1.65 | 6.06 | 18.78 | 14.47 |
| Net Profit Margin (%) | -2.24 | -1.86 | 4.21 | 14.07 | 10.83 |
| NP After MI And SOA Margin (%) | -2.24 | -1.86 | 4.21 | 14.07 | 10.83 |
| Return on Networth / Equity (%) | -3.98 | -3.38 | 7.53 | 25.91 | 14.65 |
| Return on Capital Employeed (%) | 0.28 | 0.31 | 10.74 | 30.29 | 17.08 |
| Return On Assets (%) | -1.21 | -1.16 | 3.80 | 15.10 | 8.76 |
| Long Term Debt / Equity (X) | 1.21 | 0.70 | 0.12 | 0.12 | 0.19 |
| Total Debt / Equity (X) | 1.48 | 1.01 | 0.37 | 0.14 | 0.19 |
| Asset Turnover Ratio (%) | 0.57 | 0.73 | 1.01 | 1.02 | 0.73 |
| Current Ratio (X) | 1.04 | 1.10 | 1.22 | 1.86 | 1.90 |
| Quick Ratio (X) | 0.77 | 0.85 | 0.84 | 1.42 | 1.47 |
| Inventory Turnover Ratio (X) | 8.23 | 7.31 | 5.40 | 5.68 | 3.91 |
| Dividend Payout Ratio (NP) (%) | -22.21 | -39.59 | 28.49 | 8.01 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 68.26 | 62.92 | 17.59 | 6.66 | 0.00 |
| Earning Retention Ratio (%) | 122.21 | 139.59 | 71.51 | 91.99 | 0.00 |
| Cash Earning Retention Ratio (%) | 31.74 | 37.08 | 82.41 | 93.34 | 0.00 |
| Interest Coverage Ratio (X) | 1.41 | 1.69 | 6.92 | 22.21 | 10.88 |
| Interest Coverage Ratio (Post Tax) (X) | 0.06 | 0.07 | 3.87 | 14.81 | 6.63 |
| Enterprise Value (Cr.) | 3836.01 | 2961.10 | 1656.34 | 2334.91 | 725.01 |
| EV / Net Operating Revenue (X) | 1.87 | 1.42 | 0.77 | 1.17 | 0.66 |
| EV / EBITDA (X) | 55.27 | 42.09 | 7.66 | 5.16 | 3.19 |
| MarketCap / Net Operating Revenue (X) | 1.21 | 1.15 | 0.82 | 1.36 | 0.80 |
| Retention Ratios (%) | 122.21 | 139.59 | 71.50 | 91.98 | 0.00 |
| Price / BV (X) | 2.15 | 2.09 | 1.48 | 2.51 | 1.09 |
| Price / Net Operating Revenue (X) | 1.21 | 1.15 | 0.82 | 1.36 | 0.80 |
| EarningsYield | -0.01 | -0.01 | 0.05 | 0.10 | 0.13 |
After reviewing the key financial ratios for Thirumalai Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 5. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For Diluted EPS (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 5. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 3. It has decreased from 2.38 (Mar 24) to 1.46, marking a decrease of 0.92.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 112.86. It has increased from 111.93 (Mar 24) to 112.86, marking an increase of 0.93.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 112.86. It has increased from 111.93 (Mar 24) to 112.86, marking an increase of 0.93.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 200.15. It has decreased from 203.43 (Mar 24) to 200.15, marking a decrease of 3.28.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.78. This value is within the healthy range. It has decreased from 6.87 (Mar 24) to 6.78, marking a decrease of 0.09.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.81. This value is within the healthy range. It has increased from 0.69 (Mar 24) to 0.81, marking an increase of 0.12.
- For PBT / Share (Rs.), as of Mar 25, the value is -3.99. This value is below the healthy minimum of 0. It has decreased from -3.37 (Mar 24) to -3.99, marking a decrease of 0.62.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 2. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 2. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For PBDIT Margin (%), as of Mar 25, the value is 3.38. This value is below the healthy minimum of 10. It has increased from 3.37 (Mar 24) to 3.38, marking an increase of 0.01.
- For PBIT Margin (%), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 10. It has increased from 0.34 (Mar 24) to 0.40, marking an increase of 0.06.
- For PBT Margin (%), as of Mar 25, the value is -1.99. This value is below the healthy minimum of 10. It has decreased from -1.65 (Mar 24) to -1.99, marking a decrease of 0.34.
- For Net Profit Margin (%), as of Mar 25, the value is -2.24. This value is below the healthy minimum of 5. It has decreased from -1.86 (Mar 24) to -2.24, marking a decrease of 0.38.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -2.24. This value is below the healthy minimum of 8. It has decreased from -1.86 (Mar 24) to -2.24, marking a decrease of 0.38.
- For Return on Networth / Equity (%), as of Mar 25, the value is -3.98. This value is below the healthy minimum of 15. It has decreased from -3.38 (Mar 24) to -3.98, marking a decrease of 0.60.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 10. It has decreased from 0.31 (Mar 24) to 0.28, marking a decrease of 0.03.
- For Return On Assets (%), as of Mar 25, the value is -1.21. This value is below the healthy minimum of 5. It has decreased from -1.16 (Mar 24) to -1.21, marking a decrease of 0.05.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 1.21. This value exceeds the healthy maximum of 1. It has increased from 0.70 (Mar 24) to 1.21, marking an increase of 0.51.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.48. This value exceeds the healthy maximum of 1. It has increased from 1.01 (Mar 24) to 1.48, marking an increase of 0.47.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.57. It has decreased from 0.73 (Mar 24) to 0.57, marking a decrease of 0.16.
- For Current Ratio (X), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 1.5. It has decreased from 1.10 (Mar 24) to 1.04, marking a decrease of 0.06.
- For Quick Ratio (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.77, marking a decrease of 0.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.23. This value exceeds the healthy maximum of 8. It has increased from 7.31 (Mar 24) to 8.23, marking an increase of 0.92.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -22.21. This value is below the healthy minimum of 20. It has increased from -39.59 (Mar 24) to -22.21, marking an increase of 17.38.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 68.26. This value exceeds the healthy maximum of 50. It has increased from 62.92 (Mar 24) to 68.26, marking an increase of 5.34.
- For Earning Retention Ratio (%), as of Mar 25, the value is 122.21. This value exceeds the healthy maximum of 70. It has decreased from 139.59 (Mar 24) to 122.21, marking a decrease of 17.38.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 31.74. This value is below the healthy minimum of 40. It has decreased from 37.08 (Mar 24) to 31.74, marking a decrease of 5.34.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 3. It has decreased from 1.69 (Mar 24) to 1.41, marking a decrease of 0.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 3. It has decreased from 0.07 (Mar 24) to 0.06, marking a decrease of 0.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,836.01. It has increased from 2,961.10 (Mar 24) to 3,836.01, marking an increase of 874.91.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.87. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.87, marking an increase of 0.45.
- For EV / EBITDA (X), as of Mar 25, the value is 55.27. This value exceeds the healthy maximum of 15. It has increased from 42.09 (Mar 24) to 55.27, marking an increase of 13.18.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
- For Retention Ratios (%), as of Mar 25, the value is 122.21. This value exceeds the healthy maximum of 70. It has decreased from 139.59 (Mar 24) to 122.21, marking a decrease of 17.38.
- For Price / BV (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 2.15, marking an increase of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded -0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Thirumalai Chemicals Ltd:
- Net Profit Margin: -2.24%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.28% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -3.98% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.06
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.77
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 58.17)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -2.24%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Thirumalai House, Mumbai Maharashtra 400022 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. R Parthasarathy | Chairman & Managing Director |
| Mrs. Ramya Bharathram | Managing Director & CFO |
| Mr. P Mohana Chandran Nair | Director |
| Mr. Arun Alagappan | Director |
| Mrs. Bhama Krishnamurthy | Director |
| Mr. Arun Ramanathan | Director |
| Mr. R Sampath | Director |
| Mr. Rajeev M Pandia | Director |
| Mr. M Somasundaram | Director |
FAQ
What is the intrinsic value of Thirumalai Chemicals Ltd?
Thirumalai Chemicals Ltd's intrinsic value (as of 24 January 2026) is ₹30.79 which is 83.79% lower the current market price of ₹190.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,292 Cr. market cap, FY2025-2026 high/low of ₹329/186, reserves of ₹1,521 Cr, and liabilities of ₹4,345 Cr.
What is the Market Cap of Thirumalai Chemicals Ltd?
The Market Cap of Thirumalai Chemicals Ltd is 2,292 Cr..
What is the current Stock Price of Thirumalai Chemicals Ltd as on 24 January 2026?
The current stock price of Thirumalai Chemicals Ltd as on 24 January 2026 is ₹190.
What is the High / Low of Thirumalai Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Thirumalai Chemicals Ltd stocks is ₹329/186.
What is the Stock P/E of Thirumalai Chemicals Ltd?
The Stock P/E of Thirumalai Chemicals Ltd is .
What is the Book Value of Thirumalai Chemicals Ltd?
The Book Value of Thirumalai Chemicals Ltd is 129.
What is the Dividend Yield of Thirumalai Chemicals Ltd?
The Dividend Yield of Thirumalai Chemicals Ltd is 0.00 %.
What is the ROCE of Thirumalai Chemicals Ltd?
The ROCE of Thirumalai Chemicals Ltd is 0.26 %.
What is the ROE of Thirumalai Chemicals Ltd?
The ROE of Thirumalai Chemicals Ltd is 4.13 %.
What is the Face Value of Thirumalai Chemicals Ltd?
The Face Value of Thirumalai Chemicals Ltd is 1.00.